Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199361 · ClinicalTrials.gov registry record · NA
Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation
A NA study of Post-Surgical Pain, Chronic and Post-traumatic Pain, Chronic, sponsored by Florida International University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07199361: Recruiting NA study of Post-Surgical Pain, Chronic and Post-traumatic Pain, Chronic, sponsored by Florida International University.
NCT07199361 is a NA study of Post-Surgical Pain, Chronic and Post-traumatic Pain, Chronic that is actively recruiting participants, run by Florida International University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07199361, a NA study of Post-Surgical Pain, Chronic and Post-traumatic Pain, Chronic, is actively recruiting participants, sponsored by Florida International University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to uncover the Mechanisms of pain relief through the FDA-cleared peripheral transcutaneous magnetic stimulation (pTMS) device by MagVenture. 50 people with chronic pain (post-surgical or post-traumatic) will be identified and recruited. The eligibility for participation in the study will be evaluated by a series of pain and mental health questionnaires followed by quantitative sensory testing (QST) to assess response to noxious heat, cold, and pressure stimuli. Blood will be drawn to isolate plasma, serum, and leukocytes. Participants will then undergo pTMS at the site of pain for four consecutive days. At the end of the therapy, pain testing will be done again, followed by blood withdrawal to assess the changes in plasma and leukocyte levels of mediators of pain. It is anticipated that pTMS will increase mediators of pain relief and reduce inflammatory mediators. Risks: It is possible that a few participants may not respond to pTMS therapy. However, plasma analysis of mediators of pain may help stratify these participants into responders vs. non-responders. Risks associated with the study are minimal and mainly involve discomfort associated with pain testing. The importance of knowledge gained includes understanding pain relief mechanisms by medical devices such as pTMS, which will result in better pain management.
Primary Outcome
Pressure Pain Threshold. A handheld probe (Algomed, Medoc) with a small (less than ½ inch wide) rubber tip will be used to apply pressure to the participant's forearm and shoulder. The pressure will slowly increase, and the participant will be asked to click a button when they first feel pain as a result of the pressure stimulation. The pressure will be removed as soon as the participant presses this button. This particular algometer will be used because it provides the examiner with visual feed
Conditions Studied
Interventions
- DEVICE Peripheral Transcutaneous Magnetic Stimulation from MagVenture
Study Locations (1)
Florida
- Ambulatory Care Center, Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-03-24 |
| Est. Completion | 2028-02-25 |
| Phase | NA |
What NCT07199361 shows while recruiting
NCT07199361 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Post-Surgical Pain, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Peripheral Transcutaneous Magnetic Stimulation from MagVenture is the first listed.
NCT07199361 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07199361 about?
NCT07199361 is a clinical study titled "Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation". This research aims to uncover the Mechanisms of pain relief through the FDA-cleared peripheral transcutaneous magnetic stimulation (pTMS) device by MagVenture. 50 people with chronic pain (post-surgical or post-traumatic) will be identified and recruited. The eligibility for participation in the stu...
What is the current status of trial NCT07199361?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-03-24. Estimated completion is 2028-02-25.
What conditions does trial NCT07199361 study?
This clinical trial studies the following conditions: Post-Surgical Pain, Chronic, Post-traumatic Pain, Chronic.
What interventions are being tested in trial NCT07199361?
The interventions under investigation include: Peripheral Transcutaneous Magnetic Stimulation from MagVenture (DEVICE).
Who is sponsoring clinical trial NCT07199361?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07199361 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07199361's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI